Why Moderna Could Be Worth $100 Billion Within 5 Years
There are only a dozen drugmakers in the world right now with market caps of $100 billion or more. All of them have been in business for at least 40 years. Moderna (NASDAQ: MRNA) started operations a little over 10 years ago. And the biotech just might join the $100 billion club within the next five years.
At least, that's what Oppenheimer analyst Hartaj Singh thinks. But is he right? Here are three reasons why the answer could be a resounding "yes."
Image source: Getty Images.
Source Fool.com
